Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price.
Salvia is an innovative startup active in the emerging field of bioelectronics. The name Salvia is derived from the Latin word salvere, which means to stay healthy. In addition, the Salvia-plant has been used to treat headaches, pain, and mental disorders over centuries. Salvia's mission is to deliver bioelectronic solutions that restore health for people suffering from chronic migraine. Salvia aims to provide drug-free solutions that are effective and inherently side-effect free and make the novel solutions widely accessible. The Salvia team consists of experienced entrepreneurs, engineers and scientists with diverse professional backgrounds and proven track-record throughout the medical device industry (Sapiens, Medtronic, Philips, St Jude, BioSensors International, Kyphon, etc).
Neuro Event Labs is a Finnish medical technology growth company. The company’s main product monitors epilepsy patients at home and in hospital. Accurate epilepsy seizure data is collected, analyzed and relayed to the patient’s physician, who makes individual treatment decisions based on the reports. The solution has been developed on close cooperation with leading Finnish hospitals.
Private Equity Round in 2020
Blazejewski MEDI-TECH GmbH is one of the manufacturers of medical endoscopes and is known for its highly reputable rigid and semirigid 2D endoscopes.
Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
Single Use Support is produces packaging products for the transportation of liquids in the pharmaceuticals sector.
GNA Biosolutions is a molecular technology company based in Martinsried, Germany. Their breakthrough technology, Pulse Controlled Amplification, transforms molecular testing by combining ultrafast nucleic acid amplification with intrinsic sample prep, to enable powerful solutions for the laboratory, on-site applications and the Point of Care. Their vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere.
Betterguards is a next-generation sports technology company changing the game through injury prevention and performance innovation. The adaptive ankle protection system at the core of Betterguards delivers responsive ankle stabilization without restricting a full range of motion. This breakthrough ankle protection system protects athletes from sudden ankle twisting or rolling without sacrificing freedom of movement. Developed in partnership with world-class athletes, Betterguards delivers German engineering in the world's most advanced injury protection device. Founded in 2014, Betterguards is headquartered in Berlin, Germany with operations in New York City and led by CEO Tony Verutti. In 2022, Betterguards was one of five companies selected by NBA Launchpad to work alongside league and team advisors focusing on ankle injury protection and recovery, furthering its commitment to put athletes at the forefront of innovation. Connect with us to learn more about our technology, our community, and why people are at the heart of everything we do.
evitria is an established, global antibody expression service provider located in Zurich, Switzerland. They are specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies). With a track record of more than 30,000 transfections performed and more than 5,000 antibodies/antibody-based molecules expressed and purified for their clients from the Americas, Europe, Asia and Australia – ranging from academic laboratories and small biotech start-ups to global biopharmaceutical companies – you can benefit from their expertise when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.
CoreMedic was initiated in 2012 as a spin-out of the Heart Center of University of Bern, Switzerland, in order to develop an innovative treatment concept for mitral valve regurgitation (MR). The initiators of CoreMedic had a simple but challenging idea: to combine the least invasive treatment option for MR, replacement of mitral chords, and the least invasive operational procedure into one new system: ChordArt. In 2017, the development of ChordArt had progressed towards first use in a human trial, enabling CoreMedic to attract institutional financing. The company moved to RIZ-innovation center at Radolfzell, Germany, located at Lake Constance close to the Swiss border within the leading medical technology cluster of Tuttlingen, Germany. Following successful conclusion of the first human trial of ChordArt in 2018, and two-year data confirming the powerful treatment effect of the ChordArt implant in patients with severe MR, CoreMedic GmbH is tirelessly working to make the ChordArt TMVr system available to patients.
Medigroba GmbH provides healthcare services. The Company specializes in the care of patients in hospitals, nursing facilities, and at home. Medigroba serves patients in Germany.
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.
Emerging Implant Technologies designs and manufactures medical implants in the field of orthopedics. Its products include EIT cervical cages, EIT PLIF cages, and EIT TLIF cages. Emerging Implant Technologies began operation in 2014, with its headquarters in Tuttlingen in Germany. Emerging Implant Technologies operates as a subsidiary of Johnson & Johnson Medical as of September 12, 2018.
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.
Tyromotion manufactures and distributes robotic assisted and computer aided therapy units. It develops rehabilitation technologies by employing mechatronic systems. Tyromotion focuses on developing Amadeo System, a mechatronic rehabilitation device, which is used in the rehabilitation of patients exhibiting motor dysfunctions of the distal upper extremity. David Ram founded it in 2007, with headquarters in Graz in Austria with additional office in New York City.
AOT AG is a privately owned Swiss Robotic Surgery company, which spun out of the University Hospital and the University Basel (Switzerland) in 2011 and was first funded in 2012. The company is dedicated to the development, manufacturing and sales of medical devices for osteotomy pursuing the vision of contact-free bone surgery using laser, robotics and navigation systems to re-invent bone surgery (osteotomy).
Puracon provides medical packaging and logistics services in Germany. It offers contract packaging services, including inspection and cleaning, assembling, packaging, sterilization, and validations for medical products; logistics services, such as full-service, storage, and shipping; and consulting services, including support for product approvals. Puracon provides services in the areas of medical technology, pharmacology, and biotechnology. It began operation in 2003, with its headquarters in Rosenheim in Germany.
SIS SCHWAGER Group through its subsidiaries develops, produces, and sells products for the treatment of vascular disease. It began operation in 2005, with its headquarters in Winterthur in Switzerland.
ndd Medizintechnik AG manufactures pulmonary function testing products. It offers EasyOne Worldspirometer, a portable spirometer for testing; and EasyOne Pro LAB that offers spirometry, single-breath CO diffusion, and multi-breath nitrogen washout. The company also provides EasyOne Pro, a spirometry and single-breath co diffusion solution; EasyOne-Line, a spirometer with direct connectivity to the PC; and Easy on-PC, a PC spirometry solution. In addition, it offers accessories, such as disposable spirettes and barriers.
Novo Klinik-Service GmbH develops and produces fixations and pads for intensive care, anesthetic, and nursing sectors in Germany and internationally. It offers tracheostomy/laryngectomy–fixations and accessories, ventilation–fixations and accessories, and securement devices and prophylaxis; Novobil One, an ultra-light trolley that fits in various elevators; and ITS-Novo, a modular intensive care patient room. The company was founded in 1987 and is headquartered in Kerpen, Germany.
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.
GNA Biosolutions is a molecular technology company based in Martinsried, Germany. Their breakthrough technology, Pulse Controlled Amplification, transforms molecular testing by combining ultrafast nucleic acid amplification with intrinsic sample prep, to enable powerful solutions for the laboratory, on-site applications and the Point of Care. Their vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere.
SAS Délices des 7 Vallées produces frozen cakes and pastries. The company was founded in 1996 and is headquartered in Tincques, France. As of December 20, 2018, SAS Délices des 7 Vallées operates as a subsidiary of Mademoiselle Desserts SAS.
AOT AG is a privately owned Swiss Robotic Surgery company, which spun out of the University Hospital and the University Basel (Switzerland) in 2011 and was first funded in 2012. The company is dedicated to the development, manufacturing and sales of medical devices for osteotomy pursuing the vision of contact-free bone surgery using laser, robotics and navigation systems to re-invent bone surgery (osteotomy).
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.
Vimecon develops and produces laser catheters for the treatment of heart diseases with a focus on atrial fibrillation. It also manufactures products for the medical technology and biotechnology; and offers microscopically small catheters, as well as micro materials handling techniques for exact measurement and dosage. Moreover, Vimecon advises various customers from the scholar and industrial research and development. Kai U. Markus founded it in 2005, with its headquarters in Herzogenrath in Germany.
TRI Dental Implants specializes in the development, design, and manufacturing of advanced dental implant systems. The company offers a diverse range of products, including various implant types, such as soft tissue concepts, friction and bone adaptation systems, as well as sandblasted, large grit, and acid-etched surface implant systems. Their portfolio also features vent implant lines, narrow and octa implants, prosthetic products, and surgical kits tailored for dental professionals. TRI Dental Implants distributes its offerings through a network of partners in numerous countries, including Australia, China, and various European nations, while also allowing direct online orders in specific regions. Founded by Tobias S. Richter in 2010, the company is headquartered in Baar, Switzerland, and emphasizes innovative delivery methods to enhance the efficiency of dental procedures.
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.
numares GmbH is the leading company in commercial NMR-analytics in Europe and a strong partner for its customers. Their team of experts will provide you with any assistance that may be required for optimal results. They offer the full scope of performance of up to date NMR-analytics from one source. Fast, cost efficient and reliable.
Spiegelberg develops, produces, and sells catheters and probes for neurosurgical use in the brain as well as antimicrobial products to prevent hospital acquired infections. It began operation in 1986, with its headquarters in Hamburg in Germany.
Phenox develops and produces neuroradiological and radiological medical products. It offers instruments for acute ischemic strokes/aneurysms that include PCR, a miniature instrument, that aids the restoration of blood flow in the area of the brain arteries affected by an acute ischemic stroke; CRC, a mechanical thrombectomy system for the treatment of acute ischemic strokes; BONNET for the treatment of acute ischemic strokes; BONNET short, an intracranial flow restoration device; p64 Flow Modulation Device for the treatment of complex intracranial aneurysms and dissections, pCONUS Bifurcation Aneurysm Implant, to treat complex, wide-neck intracranial bifurcation aneurysms; pITA RX Neurovascular PTA Balloon Catheter; and pRESET, a thrombectomy retriever for the treatment of acute ischemic strokes. Phenox also provides implants for hemorrhagic strokes/aneurysms, including flow diverters and pORTAL Hydrophilic Steerable Guidewire. It distributes its products in Germany and internationally. Phenox began operation in 2005. It has its headquarters in Bochum in Germany.
TNI medical develops, produces, and markets diagnostic and therapeutic equipment in the field of respiratory assistance therapy. Its TNI SoftFlow System maximizes patient comfort with full respiratory support. TNI medical offers its products through its sites in Würzburg, Dessau, and Baltimore. It began operation in 2007, with its headquarters in Freiburg in Germany.
numares GmbH is the leading company in commercial NMR-analytics in Europe and a strong partner for its customers. Their team of experts will provide you with any assistance that may be required for optimal results. They offer the full scope of performance of up to date NMR-analytics from one source. Fast, cost efficient and reliable.
Biontis offers all the building blocks, from individual components to the finished process. They develop and produce analytical procedures, complete test kits, SPE columns, reagents, devices for automating the processes, quality assurance, and validation.
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, a genetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.
Micropelt started as a project of Infineon Technologies AG in cooperation with the Fraunhofer Institute for Physical Measurement Techniques (Fraunhofer IPM) in Freiburg (Germany). Now it is a StartUp which is funded by SHS, MBG, KfW Mittelstandsbank, L-Bank and IBG. Their team develops thin film thermoelectric components based on semiconductor manufacturing processes.
CryLaS designs and manufactures diode-pumped solid-state lasers in the UV, VIS, and IR for scientific and original equipment manufacturing use. It offers lasers in the UV, VIS, and IR ranges of the spectrum that are used in spectroscopy, environmental technology, analysis, and photolithography; and pulsed and CW-lasers based solely on solid state technology. CryLaS' products have applications in biotechnology, analytics, imaging, sensor systems, and micromachining. It sells its products through its distributor in Germany, Austria, Switzerland, the United States, Canada, Middle and South America, the United Kingdom, France, Spain, Italy, Japan, China, Italy, Singapore, Malaysia, Taiwan, Israel, and India. CryLaS began operation in 2004. It has its headquarters in Berlin in Germany.